Clearmind Medicine Inc. Common Shares

CMND XNAS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

Short interest (May 15)

2.0%

Borrow Fee

494.22%

↑ 42.4%

Available Shares

↓ 95.1%

Price Chart

Company Overview

Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.

Company Info

Exchange: NASDAQ

CIK: 0001892500

Asset Type: CS

Market Data

Market Cap: $2,975,576

Employees: 2

Status: Active

Short Interest

Current Borrow Fee 494.22%

Range: 491.78% - 534.81%

Available Shares 5K

Range: 0 - 5K

Recent Changes

Fee Change: ↑ 40.9%

Available Change: ↑ 233.3%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime